JEWISH GENERAL HOSPITAL

Canadian researchers are part of global efforts to test targeted alpha therapy, a new cancer treatment using radioactive alpha particles to kill cancer cells more effectively and with less damage to healthy tissue. Several therapies are in final stages of testing and could be approved by Health Canada within a few years. Potential applications include pancreatic, prostate, breast, and neuroendocrine cancers. Challenges include production of rare radioactive isotopes and high costs, with treatments expected to cost tens of thousands of dollars per dose.

Health care HR leaders face talent shortages, retention, and burnout, using tech to streamline hiring and engagement. They aim to boost efficiency, support staff, and adapt to evolving health care needs, emphasizing empathy, diversity, and inclusion for better patient outcomes.